National Medical Products Administration (NMPA) has approved the marketing of Cogriptin Tablets.

📩 info@dengyuemed.com
🔗 dengyuemed.com

#Cogriptin #Beichangping #HisunPharma #Type2Diabetes #DPP4Inhibitor #GLP1 #GIP #NMPA #ChinaPharma #InnovativeDrug #DiabetesTreatment #BloodGlucoseControl